What is the current stock price of HeartSciences Inc. (HSCS)?

As of the latest market data, HeartSciences Inc. (HSCS) is trading at $1.78. The stock has seen a loss of -7.77% today.

Does HeartSciences Inc. (HSCS) pay a dividend?

Based on current data, HeartSciences Inc. does not have a confirmed active dividend policy.

What is the market cap of HeartSciences Inc.?

The current market capitalization of HeartSciences Inc. (HSCS) is approximately unavailable.

HSCS

HeartSciences Inc.·Healthcare

1.78

7.772%(−0.15)

Market Open

Last Updated: — ET

52W L: $1.7652W H: $6.47

HSCS NEWS

globenewswire.com

May 19

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

Agreement follows Cibolo Health's endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences' ECG management platform Agreement follows Cibolo Health's endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences' ECG management platform

globenewswire.com

May 5

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

Agreement with St. Vincent Health marks HeartSciences' transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College of Cardiology Annual Scientific Session Agreement with St. Vincent Health marks HeartSciences' transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College of Cardiology Annual Scientific Session

defenseworld.net

Apr 27

Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)

Rennova Health (OTCMKTS:RNVA - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Analyst Recommendations This is a breakdown of recent

globenewswire.com

Apr 14

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), would like to remind its shareholders to vote ahead of its upcoming Annual Meeting of Shareholders (the “Annual Meeting”) which will be held virtually on Thursday, April 30, 2026, at 10:00 a.m. Eastern Time. All shareholders of record of HeartSciences' outstanding shares of common stock and Series C preferred stock at the close of business on March 6, 2026, are entitled to participate and vote at the Annual Meeting.

defenseworld.net

Apr 10

Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)

10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation. Institutional and Insider Ownership 84.7% of 10x Genomics shares

defenseworld.net

Mar 26

Hinge Health (NYSE:HNGE) versus HeartSciences (NASDAQ:HSCS) Financial Analysis

HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Valuation and Earnings This table compares HeartSciences and Hinge

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2022-06-16

Beta

2.04

Websiteheartsciences.com↗